Biopharmaceuticals
FDA
Cardiology
News Release - November 9, 2007
CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol
Source: AstraZeneca
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.